These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15464381)

  • 1. Downstream processing of recombinant proteins from transgenic feedstock.
    Nikolov ZL; Woodard SL
    Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant proteins in suspension-cultured plant cells.
    Plasson C; Michel R; Lienard D; Saint-Jore-Dupas C; Sourrouille C; de March GG; Gomord V
    Methods Mol Biol; 2009; 483():145-61. PubMed ID: 19183898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bench to batch: advances in plant cell culture for producing useful products.
    Weathers PJ; Towler MJ; Xu J
    Appl Microbiol Biotechnol; 2010 Feb; 85(5):1339-51. PubMed ID: 19956945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plant-made pharmaceuticals].
    Faye L; Lerouge P; Gomord V
    Ann Pharm Fr; 2003 Mar; 61(2):109-18. PubMed ID: 12668949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharming and transgenic plants.
    Liénard D; Sourrouille C; Gomord V; Faye L
    Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of heterologous proteins in plants: strategies for optimal expression.
    Desai PN; Shrivastava N; Padh H
    Biotechnol Adv; 2010; 28(4):427-35. PubMed ID: 20152894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-based production of xenogenic proteins.
    Hood EE; Jilka JM
    Curr Opin Biotechnol; 1999 Aug; 10(4):382-6. PubMed ID: 10449314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of therapeutic proteins in the milk of transgenic livestock.
    Colman A
    Biochem Soc Symp; 1998; 63():141-7. PubMed ID: 9513718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic chickens as bioreactors for protein-based drugs.
    Lillico SG; McGrew MJ; Sherman A; Sang HM
    Drug Discov Today; 2005 Feb; 10(3):191-6. PubMed ID: 15708533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe and acceptable strategies for producing foreign molecules in plants.
    Mascia PN; Flavell RB
    Curr Opin Plant Biol; 2004 Apr; 7(2):189-95. PubMed ID: 15003220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants.
    Chen M; Liu X; Wang Z; Song J; Qi Q; Wang PG
    Med Res Rev; 2005 May; 25(3):343-60. PubMed ID: 15499575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental models of transgenic plants promising for the modern technologies].
    Abdeeva IA; Goldenkova-Pavlova IV; Mokriakova MV; Volkova LV; Bogush VG; Sidoruk KV; Iur'eva NO; Debabov VG; Piruzian ES
    Tsitol Genet; 2007; 41(3):55-61. PubMed ID: 17649625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteinase inhibitors in plant biotechnology: a review].
    Mosolov VV; Valueva TA
    Prikl Biokhim Mikrobiol; 2008; 44(3):261-9. PubMed ID: 18663947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.